Hamostaseologie 2025; 45(S 01): S57-S58
DOI: 10.1055/s-0044-1801631
DOI: 10.1055/s-0044-1801631
Abstracts
Topics
T-07 Hereditary bleeding disorders
Perioperative Management with Efanesoctocog Alfa in Adults, Adolescents, and Children with Severe Hemophilia A in the Phase 3 XTEND Clinical Program
Authors
-
A K Chan
1 McMaster Children’s Hospital, McMaster University, Hamilton, Canada -
S Susen
2 Université de Lille, Centre Hospitalier Universitaire de Lille, Lille, France -
L Khoo
3 Royal Prince Alfred Hospital, Sydney, Australia -
A von Drygalski
4 University of California, Division of Hematology/Oncology, Department of Medicine, San Diego, USA -
J Oldenburg
5 University Hospital Bonn, Bonn, Germany -
M-C Shen
6 Changhua Christian Hospital, Division of Hematology-Oncology, Department of Internal Medicine, Changhua 50046, Taiwan7 National Taiwan University Hospital, Department of Internal Medicine and Laboratory Medicine, 100 Taipei, Germany -
F Peyvandi
8 IRCCS Ca' Granda Maggiore Hospital Foundation, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy9 Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milano, Italy -
C Tarango
10 University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA11 Cincinnati Children's Hospital Medical Center, Division of Hematology, Cincinnati, USA -
P Chowdary
12 Royal Free Hospital, Katharine Dormandy Haemophilia and Thrombosis Centre, London, UK -
L Mamikonian
13 Sanofi, Cambridge, USA -
H Palmborg
14 Sobi, Stockholm, Sweden -
J Dumont
13 Sanofi, Cambridge, USA -
E Santagostino
15 Sobi, Basel, Switzerland -
C Hermans
16 Saint-Luc University Hospital, Université Catholique de Louvain, Division of Haematology, Haemostasis and Thrombosis Unit, Brussels, Belgium
